Entrada Therapeutics, Inc. · NASDAQ:TRDA

Sethuraman Natarajan sold 25,907 Entrada Therapeutics, Inc. shares (Form 4)

Traded May 4, 2026 · Filed May 4, 2026

On May 4, 2026, Sethuraman Natarajan (President, Research & Develop.) sold 25,907 Entrada Therapeutics, Inc. shares at US$15.39 for US$399K under a trading plan, leaving 216,317 shares. Filed May 4, 2026 (Form 4).

Sold
25,907 shares
Price
US$15.39
Value
US$399K
Holding after
216,317 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, Research & Develop.

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockSale25,907US$15.39216,317Direct

Source

View original at SEC

Related